• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤缺氧的正电子发射断层扫描(PET)和磁共振成像(MRI)成像进展。

Advances in PET and MRI imaging of tumor hypoxia.

作者信息

Gouel Pierrick, Decazes Pierre, Vera Pierre, Gardin Isabelle, Thureau Sébastien, Bohn Pierre

机构信息

Département d'Imagerie, Centre Henri Becquerel, Rouen, France.

QuantIF-LITIS, EA 4108, IRIB, Université de Rouen, Rouen, France.

出版信息

Front Med (Lausanne). 2023 Feb 9;10:1055062. doi: 10.3389/fmed.2023.1055062. eCollection 2023.

DOI:10.3389/fmed.2023.1055062
PMID:36844199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9947663/
Abstract

Tumor hypoxia is a complex and evolving phenomenon both in time and space. Molecular imaging allows to approach these variations, but the tracers used have their own limitations. PET imaging has the disadvantage of low resolution and must take into account molecular biodistribution, but has the advantage of high targeting accuracy. The relationship between the signal in MRI imaging and oxygen is complex but hopefully it would lead to the detection of truly oxygen-depleted tissue. Different ways of imaging hypoxia are discussed in this review, with nuclear medicine tracers such as [F]-FMISO, [F]-FAZA, or [Cu]-ATSM but also with MRI techniques such as perfusion imaging, diffusion MRI or oxygen-enhanced MRI. Hypoxia is a pejorative factor regarding aggressiveness, tumor dissemination and resistance to treatments. Therefore, having accurate tools is particularly important.

摘要

肿瘤缺氧在时间和空间上都是一种复杂且不断演变的现象。分子成像能够探究这些变化,但所使用的示踪剂有其自身局限性。正电子发射断层显像(PET)成像的缺点是分辨率低且必须考虑分子生物分布,但具有高靶向准确性的优点。磁共振成像(MRI)中的信号与氧气之间的关系很复杂,但有望实现对真正缺氧组织的检测。本综述讨论了不同的缺氧成像方法,包括使用核医学示踪剂如[F]-氟代米索([F]-FMISO)、[F]-氟阿扎([F]-FAZA)或[Cu]-乙硫半胱氨酸([Cu]-ATSM),也包括使用MRI技术如灌注成像、扩散加权磁共振成像(DWI)或氧增强磁共振成像。缺氧是与肿瘤侵袭性、播散及治疗抵抗相关的不良因素。因此,拥有精确的工具尤为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/4947f6ab04f5/fmed-10-1055062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/f17501df96dc/fmed-10-1055062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/29fd1dc4bb43/fmed-10-1055062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/c82594eaea44/fmed-10-1055062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/4947f6ab04f5/fmed-10-1055062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/f17501df96dc/fmed-10-1055062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/29fd1dc4bb43/fmed-10-1055062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/c82594eaea44/fmed-10-1055062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9947663/4947f6ab04f5/fmed-10-1055062-g004.jpg

相似文献

1
Advances in PET and MRI imaging of tumor hypoxia.肿瘤缺氧的正电子发射断层扫描(PET)和磁共振成像(MRI)成像进展。
Front Med (Lausanne). 2023 Feb 9;10:1055062. doi: 10.3389/fmed.2023.1055062. eCollection 2023.
2
The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.使用[64Cu]Cu-ATSM或[18F]氟米索硝唑正电子发射断层扫描技术研究肿瘤氧合对小鼠鳞状细胞癌缺氧成像的影响。
Int J Oncol. 2007 Apr;30(4):873-81.
3
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.18F-氟阿霉素阿拉伯呋喃糖苷与 64Cu-二乙酰基双(N4-甲基硫代半卡巴腙)在癌症临床前模型中的比较。
J Nucl Med. 2013 Jul;54(7):1106-12. doi: 10.2967/jnumed.112.111120. Epub 2013 May 22.
4
A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.四种缺氧 PET 示踪剂的影像特征和微区分布比较。
J Nucl Med. 2014 Mar;55(3):515-21. doi: 10.2967/jnumed.113.126615. Epub 2014 Feb 3.
5
A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].1-(5-氟-5-脱氧-α-D-阿拉伯呋喃糖基)-2-硝基咪唑与双乙酰双[N(4)-甲基硫代半卡巴腙]铜在肿瘤内分布的重叠有限。
Oncol Rep. 2015 Sep;34(3):1379-87. doi: 10.3892/or.2015.4079. Epub 2015 Jun 25.
6
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.使用18F-氟米索硝唑和64Cu(II)-二乙酰基双(N4-甲基硫代半卡巴腙)正电子发射断层扫描评估局部肿瘤缺氧:在R3327-AT和FaDu大鼠肿瘤模型中进行的包括微型PET成像、氧分压探针测量、放射自显影和荧光显微镜检查的比较研究。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1493-502. doi: 10.1016/j.ijrobp.2004.12.057.
7
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.用于肿瘤缺氧成像的正电子发射断层显像(PET)放射性药物:证据综述
Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014.
8
Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.使用(18)F-FAZA和(62)Cu-ATSM的缺氧PET在非小细胞肺癌中的预后意义
Lung Cancer. 2016 Jan;91:56-66. doi: 10.1016/j.lungcan.2015.11.020. Epub 2015 Nov 28.
9
Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging.聚焦正电子发射断层扫描(PET)成像中(64)Cu-ATSM 对肿瘤乏氧显影的争议方面。
Front Med (Lausanne). 2015 Aug 24;2:58. doi: 10.3389/fmed.2015.00058. eCollection 2015.
10
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.[18F]-氟代米索与[18F]-法扎在肺癌术前缺氧正电子发射断层显像中的首次比较。
Cancers (Basel). 2021 Aug 14;13(16):4101. doi: 10.3390/cancers13164101.

引用本文的文献

1
Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma.短暂性肝实质强化差异:与肝细胞癌经动脉化疗栓塞术治疗后的疗效及不良事件的相关性
Insights Imaging. 2025 Aug 1;16(1):164. doi: 10.1186/s13244-025-02041-2.
2
Advances in multimodal imaging techniques in nanomedicine: enhancing drug delivery precision.纳米医学中多模态成像技术的进展:提高药物递送精度
RSC Adv. 2025 Jul 30;15(33):27187-27209. doi: 10.1039/d5ra03255e. eCollection 2025 Jul 25.
3
Use of Radiomics in Characterizing Tumor Hypoxia.

本文引用的文献

1
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer.多模态 MRI 和 18F-FDG-PET/CT 识别局部晚期宫颈癌放化疗后复发风险。
Radiother Oncol. 2022 Nov;176:17-24. doi: 10.1016/j.radonc.2022.09.002. Epub 2022 Sep 14.
2
The imaging of the hypoxic microenvironment in tumorous tissue using PET/CT and PET/MRI.使用 PET/CT 和 PET/MRI 对肿瘤组织缺氧微环境进行成像。
Eur J Radiol. 2022 Sep;154:110458. doi: 10.1016/j.ejrad.2022.110458. Epub 2022 Jul 29.
3
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.
放射组学在肿瘤缺氧特征描述中的应用。
Int J Mol Sci. 2025 Jul 11;26(14):6679. doi: 10.3390/ijms26146679.
4
Development of Stimuli-Responsive Polymeric Nanomedicines in Hypoxic Tumors and Their Therapeutic Promise in Oral Cancer.缺氧肿瘤中刺激响应性聚合物纳米药物的研发及其在口腔癌治疗中的前景
Polymers (Basel). 2025 Apr 9;17(8):1010. doi: 10.3390/polym17081010.
5
Tumor microenvironment and fibroblast activation protein inhibitor (FAPI) PET: developments toward brain imaging.肿瘤微环境与成纤维细胞活化蛋白抑制剂(FAPI)PET:脑成像的进展
Front Nucl Med. 2023 Jul 18;3:1183471. doi: 10.3389/fnume.2023.1183471. eCollection 2023.
6
Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective.时空代谢组学方法研究癌症免疫全景:一种方法学视角。
Mol Cancer. 2024 Sep 18;23(1):202. doi: 10.1186/s12943-024-02113-9.
7
Diffuse reflectance spectroscopy for optical characterizations of orthotopic head and neck cancer models .用于原位头颈癌模型光学表征的漫反射光谱法
Biomed Opt Express. 2024 Jun 10;15(7):4176-4189. doi: 10.1364/BOE.528608. eCollection 2024 Jul 1.
8
Design and evaluation of a pneumatic actuation unit for a wasp-inspired self-propelled needle.仿黄蜂自驱式针刺驱动器气动致动单元的设计与评估
PLoS One. 2024 Jul 2;19(7):e0306411. doi: 10.1371/journal.pone.0306411. eCollection 2024.
9
The development process of 'fit-for-purpose' imaging biomarkers to characterize the tumor microenvironment.用于表征肿瘤微环境的“适用型”成像生物标志物的开发过程。
Front Med (Lausanne). 2024 May 16;11:1347267. doi: 10.3389/fmed.2024.1347267. eCollection 2024.
10
DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway.DKK2 通过 PI3K/AKT 信号通路促进口腔鳞状细胞癌的进展。
Aging (Albany NY). 2024 May 24;16(10):9204-9215. doi: 10.18632/aging.205864.
通过PET和MRI解码恶性胶质瘤的异质性以进行缺氧、灌注和扩散成像的空间栖息地分析:一项初步研究
Front Neurosci. 2022 Jul 13;16:885291. doi: 10.3389/fnins.2022.885291. eCollection 2022.
4
The optimal F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO electron paramagnetic resonance imaging as reference truth.使用 pO2 电子顺磁共振成像作为参考真值,优化 F-氟代米索硝唑 PET 阈值以定义临床前鳞状细胞癌中的肿瘤缺氧。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4014-4024. doi: 10.1007/s00259-022-05889-4. Epub 2022 Jul 6.
5
PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study.新型镓 68 标记缺氧探针在诊断为结核病患者中的 PET/CT 特征:一项概念验证研究。
Nucl Med Commun. 2022 Jul 1;43(7):787-793. doi: 10.1097/MNM.0000000000001580. Epub 2022 May 4.
6
Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET.用于正电子发射断层显像(PET)的放射性核素标记示踪剂对肿瘤缺氧的成像
Front Oncol. 2021 Sep 7;11:731503. doi: 10.3389/fonc.2021.731503. eCollection 2021.
7
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.[18F]-氟代米索与[18F]-法扎在肺癌术前缺氧正电子发射断层显像中的首次比较。
Cancers (Basel). 2021 Aug 14;13(16):4101. doi: 10.3390/cancers13164101.
8
Monitoring Treatment Efficacy of Antiangiogenic Therapy Combined With Hypoxia-Activated Prodrugs Online Using Functional MRI.使用功能磁共振成像在线监测抗血管生成疗法联合缺氧激活前药的治疗效果
Front Oncol. 2021 Apr 30;11:672047. doi: 10.3389/fonc.2021.672047. eCollection 2021.
9
Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics.用于靶向肿瘤乏氧的 Ga 标记 PET 示踪剂:双功能螯合剂对药代动力学的作用。
Nucl Med Biol. 2021 May-Jun;96-97:61-67. doi: 10.1016/j.nucmedbio.2021.03.004. Epub 2021 Mar 26.
10
Phase I study to assess safety, biodistribution and radiation dosimetry for Zr-girentuximab in patients with renal cell carcinoma.Zr-吉妥珠单抗治疗肾细胞癌患者的 I 期研究:评估安全性、生物分布和辐射剂量学。
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3277-3285. doi: 10.1007/s00259-021-05271-w. Epub 2021 Mar 2.